Примери за използване на Number of patients who на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Even now, the number of patients who die in hospitals is increasing.
The main measure of effectiveness was the number of patients who were cured.
Number of patients who had SREs(%) Median time to SRE(months).
The study measured the number of patients who responded to treatment.
The number of patients who have already managed to help with problems of the back and neck has more than 2000!
Хората също превеждат
The main measure of effectiveness was the number of patients who‘ responded' to treatment.
Further, the number of patients who achieve a complete remission is also much higher," Smith says.
Procedural site reaction a Calculated based on total number of patients who received ADVATE(418).
It reduced the number of patients who experienced a severe asthma exacerbation.
Ed chemotherapy, the main measure of effectiveness was the reduction in number of patients who needed a blood transfusion.
It includes the number of patients who survive 5 years after establishing an accurate diagnosis.
The main measure of effectiveness in all these studies was the number of patients who had a complete or partial response to treatment.
NNT: Number of patients who need to be treated to prevent one additional adverse outcome.
The main measure of effectiveness was the number of patients who were alive 30 days after treatment.
NNT is the number of patients who need to be treated in order to prevent one additional bad outcome.
The partnership could significantly increase the number of patients who can benefit this innovative treatment.
The number of patients who responded to treatment was also higher in the Instanyl group than in the placebo group.
The main measure of effectiveness was the number of patients who survived without the disease coming back.
N1: number of patients who achieved MRD response and the respective remission status; n2: number of patients who achieved the respective remission status.
All of the studies measured the number of patients who did not vomit after receiving chemotherapy.
The number of patients who completed the study treatment(10 cycles) was respectively 29.4% and 13.5% in the JEVTANA group and in the comparator group.
The main measure of effectiveness was the number of patients who‘responded' after at least five weeks of treatment.
Tecfidera has been shown to reduce the number of relapses in patients with relapsing-remitting MS and to reduce the number of patients who have them.
These studies measured the number of patients who stopped treatment because they were not getting enough pain relief.
In patients receiving chemotherapy, the main measure of effectiveness was the reduction in number of patients who needed a blood transfusion.
The main measure of effectiveness was the number of patients who had no nausea and vomiting in the five days after receiving chemotherapy.
Tecfidera has been shown to be effective in reducing the number of relapses in patients with relapsingremitting MS and in reducing the number of patients who have relapses during treatment.
The main measure of effectiveness was based on the number of patients who showed a partial or complete response to treatment.
The scientists also tracked the number of patients who needed further treatment following HIFU,(such as surgery or radiotherapy), to treat any cancer cells that had returned.
The studies compared Rizmoicwith placebo(a dummy treatment) to see if treatment would consistently increase the number of patients who can pass stools and allow them to do so at least 3 times a week during treatment.